Inhibition of Myofibroblast Apoptosis by Transforming Growth Factor β1
暂无分享,去创建一个
[1] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[2] L. Barbeito,et al. Nitric Oxide and Superoxide Contribute to Motor Neuron Apoptosis Induced by Trophic Factor Deprivation , 1998, The Journal of Neuroscience.
[3] T. McDonnell,et al. Bcl-2 suppresses apoptosis resulting from disruption of the NF-κB survival pathway , 1997 .
[4] G. Owens,et al. A Transforming Growth Factor β (TGFβ) Control Element Drives TGFβ-induced Stimulation of Smooth Muscle α-Actin Gene Expression in Concert with Two CArG Elements* , 1997, The Journal of Biological Chemistry.
[5] A. van Dam,et al. Inhibition of endotoxin‐induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: A role for transforming growth factor β , 1997 .
[6] Z. Melkova,et al. Bcl‐2 prevents nitric oxide‐mediated apoptosis and poly(ADP‐ribose) polymerase cleavage , 1997, FEBS letters.
[7] M. Todaro,et al. Potential Involvement of Fas and Its Ligand in the Pathogenesis of Hashimoto's Thyroiditis , 1997, Science.
[8] S. Phan,et al. Regulation of lung fibroblast alpha-smooth muscle actin expression, contractile phenotype, and apoptosis by IL-1beta. , 1997, Journal of immunology.
[9] S. Orrenius,et al. Signal Transduction Pathways in Apoptosis , 1996, Trends in cell biology.
[10] C. Lowenstein,et al. Transcriptional regulation of iNOS by IL-1 beta in cultured rat pulmonary artery smooth muscle cells. , 1996, The American journal of physiology.
[11] O. Seternes,et al. Macrophage cytotoxicity against murine meth A sarcoma involves nitric oxide-mediated apoptosis. , 1996, Biochemical and biophysical research communications.
[12] C. Patterson,et al. Suppression of Interleukin-1β-induced Nitric-oxide Synthase Promoter/Enhancer Activity by Transforming Growth Factor-β1 in Vascular Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.
[13] S. Phan,et al. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. , 1996, The American journal of pathology.
[14] A. Prochiantz,et al. Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[15] D. Laskin,et al. Unique patterns of regulation of nitric oxide production in fibroblasts , 1995, Journal of leukocyte biology.
[16] V. Wahn,et al. Nitric oxide induces apoptosis in mouse thymocytes. , 1995, Journal of immunology.
[17] L. Juillerat-Jeanneret,et al. Involvement of a transforming‐growth‐factor‐β‐like molecule in tumor‐cell‐derived inhibition of nitric‐oxide synthesis in cerebral endothelial cells , 1995, International journal of cancer.
[18] K. Chadee,et al. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica. , 1995, Immunology.
[19] A. Desmoulière,et al. Factors influencing myofibroblast differentiation during wound healing and fibrosis. , 1995, Cell biology international.
[20] D. Geller,et al. TGF-beta regulates production of NO in pulmonary artery smooth muscle cells by inhibiting expression of NOS. , 1995, The American journal of physiology.
[21] I. Fidler,et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells , 1995, The Journal of experimental medicine.
[22] S. Phan,et al. Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. , 1994, Journal of immunology.
[23] B. Brüne,et al. Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. , 1994, Experimental cell research.
[24] M. Rekhter,et al. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. , 1994, The American journal of pathology.
[25] J. Tsai,et al. Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells. , 1994, The Journal of biological chemistry.
[26] P. Guerne,et al. Growth factor responsiveness of human articular chondrocytes: Distinct profiles in primary chondrocytes, subcultured chondrocytes, and fibroblasts , 1994, Journal of cellular physiology.
[27] D. Reis,et al. Cloning and expression of inducible nitric oxide synthase from rat astrocytes , 1994, Journal of neuroscience research.
[28] A. Desmoulière,et al. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts , 1993, The Journal of cell biology.
[29] O. Petersen,et al. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[30] P. Jorens,et al. Synergism between interleukin-1ß and interferon-γ, an inducer of nitric oxide synthase, in rat lung fibroblasts , 1992 .
[31] C. Heldin,et al. Regulation of fibroblast-mediated collagen gel contraction by platelet-derived growth factor, interleukin-1 alpha and transforming growth factor-beta 1. , 1992, Journal of cell science.
[32] D. Beasley,et al. Interleukin-1 beta alters actin expression and inhibits contraction of rat thoracic aorta. , 1992, The American journal of physiology.
[33] J. McDonald,et al. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. , 1991, The American journal of pathology.
[34] J. Rosenbloom,et al. Cytokine networks in the regulation of inflammation and fibrosis in the lung. , 1990, Chest.
[35] K. Leslie,et al. Alpha-smooth muscle actin in parenchymal cells of bleomycin-injured rat lung. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[36] J. Elias. Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via fibroblast prostaglandin-dependent and -independent mechanisms. , 1988, The American review of respiratory disease.
[37] L Orci,et al. Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Varani,et al. Rat lung fibroblast collagen metabolism in bleomycin-induced pulmonary fibrosis. , 1985, The Journal of clinical investigation.
[39] C. Dani,et al. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues. , 1984, Nucleic acids research.
[40] K. Adler,et al. Actin content of normal and of bleomycin-fibrotic rat lung. , 1984, The American review of respiratory disease.
[41] K. Flanders,et al. Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis. , 1995, The American journal of pathology.
[42] A. Desmoulière,et al. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. , 1995, The American journal of pathology.
[43] R. Ochs,et al. Chondrocyte apoptosis induced by nitric oxide. , 1995, The American journal of pathology.
[44] S. Kunkel,et al. Lung cytokine production in bleomycin-induced pulmonary fibrosis. , 1992, Experimental lung research.
[45] R. Cohen,et al. Interleukin 1 inhibits contraction of vascular smooth muscle. , 1989, The Journal of clinical investigation.